Pacira Pharmaceuticals to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference
September 20 2017 - 7:30AM
Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) today announced that
members of its management team are scheduled to present at the 2017
Cantor Fitzgerald Global Healthcare Conference at 10:20 AM ET on
Tuesday, September 26, 2017 in New York City.
A live audio webcast of the Pacira presentation can be accessed
by visiting the “Investors & Media” section of the company’s
website at investor.pacira.com. A replay of the webcast will be
archived on the Pacira website for two weeks following the
presentation date.
About Pacira
Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) is a specialty
pharmaceutical company focused on the clinical and commercial
development of new products that meet the needs of acute care
practitioners and their patients. The company’s flagship product,
EXPAREL® (bupivacaine liposome injectable suspension), indicated
for single-dose infiltration into the surgical site to produce
postsurgical analgesia, was commercially launched in the United
States in April 2012. EXPAREL and two other products have
successfully utilized DepoFoam®, a unique and proprietary product
delivery technology that encapsulates drugs without altering their
molecular structure, and releases them over a desired period of
time. Additional information about Pacira is available at
www.pacira.com.
Company Contact:
Pacira Pharmaceuticals, Inc.
Susan Mesco
(973) 451-4030
Susan.mesco@pacira.com
Pacira BioSciences (NASDAQ:PCRX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Pacira BioSciences (NASDAQ:PCRX)
Historical Stock Chart
From Sep 2023 to Sep 2024